Free Trial
→ Trump purposefully forcing markets to crash… (From Porter & Company) (Ad) Buy NNOX Stock  Free NNOX Stock Alerts

Nano-X Imaging (NNOX) Financials

Nano-X Imaging logo
$5.10 +0.12 (+2.41%)
Closing price 04/23/2025 04:00 PM Eastern
Extended Trading
$5.12 +0.02 (+0.29%)
As of 04/23/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Nano-X Imaging

Annual Income Statements for Nano-X Imaging

This table shows Nano-X Imaging's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -1.91 -23 -44 -62 -113 -61 -54
Consolidated Net Income / (Loss)		 -1.91 -23 -44 -62 -113 -61 -54
Net Income / (Loss) Continuing Operations		 -1.90 -23 -44 -62 -113 -61 -54
Total Pre-Tax Income 		-1.90 -23 -44 -62 -117 -61 -54
Total Operating Income		 -1.90 -23 -44 -62 -118 -63 -57
Total Gross Profit		 0.00 0.00 0.00 -1.51 -6.88 -6.59 -11
Total Revenue		 0.00 0.00 0.00 1.30 8.58 9.91 11
Operating Revenue		 - 0.00 0.00 1.30 8.58 9.91 11
Total Cost of Revenue		 0.00 0.00 0.00 2.82 15 16 22
Operating Cost of Revenue		 - 0.00 0.00 2.82 15 16 22
Total Operating Expenses		 1.90 23 44 60 131 60 46
Selling, General & Admin Expense		 1.02 18 22 35 41 24 22
Marketing Expense		 0.21 1.56 12 7.03 4.38 4.17 3.41
Research & Development Expense		 0.67 2.72 9.21 17 27 26 20
Other Operating Expenses / (Income)		 - - - 1.18 8.19 -1.42 0.09
Impairment Charge		 - - 0.00 0.00 51 7.42 0.00
Total Other Income / (Expense), net		 0.00 0.01 0.11 -0.61 21 5.80 3.18
Interest & Investment Income		 - 0.01 0.11 0.00 0.79 -0.18 2.87
Other Income / (Expense), net		 - 0.00 0.00 -0.61 20 5.98 0.31
Income Tax Expense		 - 0.00 0.00 -0.05 -3.68 -0.34 -0.36
Basic Earnings per Share		 ($0.09) ($0.90) ($1.23) ($1.28) ($2.17) ($1.08) ($0.91)
Weighted Average Basic Shares Outstanding		 20.79M 25.18M 35.65M 48.22M 52.24M 56.37M 58.67M
Weighted Average Diluted Shares Outstanding		 20.79M 25.18M 35.65K 51.79M 55.09M 57.78M 58.67M
Weighted Average Basic & Diluted Shares Outstanding		 20.79M 25.18M 35.65K 51.79M 55.09M 57.78M 58.67M

Quarterly Income Statements for Nano-X Imaging

No quarterly income statements for Nano-X Imaging are available.

Annual Cash Flow Statements for Nano-X Imaging

This table details how cash moves in and out of Nano-X Imaging's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 -0.06 8.21 206 -147 -28 18 -17
Net Cash From Operating Activities		 -3.67 -5.52 -22 -38 -43 -45 -37
Net Cash From Continuing Operating Activities		 -3.67 -5.52 -22 -38 -43 -45 -37
Net Income / (Loss) Continuing Operations		 -1.91 -23 -44 -62 -113 -61 -54
Consolidated Net Income / (Loss)		 -1.91 -23 -44 -62 -113 -61 -54
Depreciation Expense		 0.04 0.05 0.21 0.52 0.91 1.20 1.12
Amortization Expense		 - 0.00 0.00 1.55 12 11 10
Non-Cash Adjustments To Reconcile Net Income		 0.12 16 25 19 70 16 6.95
Changes in Operating Assets and Liabilities, net		 -1.91 0.74 -2.66 2.63 -13 -12 -1.50
Net Cash From Investing Activities		 -0.07 -0.13 -14 -116 15 35 -20
Net Cash From Continuing Investing Activities		 -0.07 -0.13 -14 -116 15 35 -20
Purchase of Property, Plant & Equipment		 -0.07 -0.13 -14 -23 -7.17 -3.30 -2.77
Acquisitions		 - 0.00 0.00 -2.86 -1.01 0.00 0.00
Purchase of Investments		 - 0.00 0.00 -104 -8.45 0.00 -59
Sale and/or Maturity of Investments		 - - 0.00 14 31 39 41
Other Investing Activities, net		 - - - 0.00 0.00 -0.37 0.05
Net Cash From Financing Activities		 3.68 14 241 7.38 0.80 27 40
Net Cash From Continuing Financing Activities		 3.68 14 241 7.38 0.80 27 40
Repayment of Debt		 0.00 -0.34 0.00 0.00 -0.15 0.00 0.00
Issuance of Common Equity		 3.68 14 240 0.00 0.00 27 38
Other Financing Activities, net		 0.00 0.16 0.63 3.58 0.95 0.11 1.67
Cash Interest Paid		 - - 0.00 0.01 0.09 0.15 0.14
Cash Income Taxes Paid		 - - 0.01 0.01 0.15 0.00 0.05

Quarterly Cash Flow Statements for Nano-X Imaging

No quarterly cash flow statements for Nano-X Imaging are available.

Annual Balance Sheets for Nano-X Imaging

This table presents Nano-X Imaging's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Total Assets		 12 236 363 254 219 210
Total Current Assets		 9.64 220 95 82 89 79
Cash & Equivalents		 8.07 213 67 38 56 39
Restricted Cash		 - - - 0.00 0.05 0.00
Short-Term Investments		 - 0.00 22 39 26 18
Accounts Receivable		 - 0.00 1.05 0.98 1.48 1.81
Inventories, net		 - - - 0.00 2.36 1.49
Prepaid Expenses		 1.56 4.79 3.13 2.41 1.27 0.83
Other Current Assets		 - 1.54 1.97 1.45 1.09 17
Plant, Property, & Equipment, net		 0.23 14 37 44 42 45
Total Noncurrent Assets		 2.01 2.34 231 128 88 86
Intangible Assets		 - 0.00 102 91 81 70
Other Noncurrent Operating Assets		 2.01 2.34 2.91 4.09 7.06 16
Total Liabilities & Shareholders' Equity		 12 236 363 254 219 210
Total Liabilities		 21 5.40 71 37 23 21
Total Current Liabilities		 20 4.48 53 25 16 14
Short-Term Debt		 0.14 0.00 0.15 4.25 3.49 3.06
Accounts Payable		 0.55 0.44 3.13 3.62 3.30 2.21
Accrued Expenses		 1.83 1.93 3.61 12 3.92 3.97
Current Deferred Revenue		 - 0.00 0.25 0.18 0.54 0.14
Other Current Liabilities		 18 2.11 46 4.78 4.27 4.59
Total Noncurrent Liabilities		 0.39 0.92 18 12 7.61 6.91
Noncurrent Deferred & Payable Income Tax Liabilities		 - 0.00 7.06 3.33 2.95 2.58
Other Noncurrent Operating Liabilities		 0.39 0.92 7.00 4.97 4.66 4.34
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -8.78 231 292 217 196 189
Total Preferred & Common Equity		 -8.78 231 292 217 196 189
Total Common Equity		 -8.78 231 292 217 196 189
Common Stock		 32 315 439 478 516 563
Retained Earnings		 -41 -84 -146 -259 -320 -374
Accumulated Other Comprehensive Income / (Loss)		 - 0.00 -0.61 -1.97 -0.31 -0.00

Quarterly Balance Sheets for Nano-X Imaging

No quarterly balance sheets for Nano-X Imaging are available.

Annual Metrics and Ratios for Nano-X Imaging

This table displays calculated financial ratios and metrics derived from Nano-X Imaging's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 557.82% 15.47% 13.91%
EBITDA Growth		 0.00% -1,104.82% -94.13% -37.46% -40.50% 47.81% 1.29%
EBIT Growth		 0.00% -1,085.45% -94.60% -41.53% -56.57% 41.84% 2.86%
NOPAT Growth		 0.00% -1,085.45% -94.60% -40.15% -91.22% 46.83% 9.34%
Net Income Growth		 0.00% -1,081.93% -94.19% -41.04% -83.25% 46.33% 11.95%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 0.00% -50.48% -291.18% -76.13% -13.99% -3.21% 18.27%
Free Cash Flow Firm Growth		 0.00% 0.00% -7,211.29% -155.42% 61.02% 39.80% -48.51%
Invested Capital Growth		 0.00% 0.00% 203.40% 707.58% -12.86% -4.12% 15.35%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% -115.95% -80.21% -66.55% -94.03%
EBITDA Margin		 0.00% 0.00% 0.00% -4,608.05% -984.19% -444.88% -398.54%
Operating Margin		 0.00% 0.00% 0.00% -4,720.71% -1,372.23% -631.89% -502.93%
EBIT Margin		 0.00% 0.00% 0.00% -4,767.25% -1,134.69% -571.53% -500.22%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% -4,739.11% -1,320.16% -613.59% -474.31%
Tax Burden Percent		 100.26% 100.00% 100.00% 99.92% 96.85% 99.45% 99.34%
Interest Burden Percent		 100.00% 99.96% 99.75% 99.49% 120.12% 107.96% 95.45%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% -54.96% -63.11% -36.79% -31.65%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% -44.74% -38.20% -17.30% -10.99%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 31.32% 18.60% 7.30% 3.82%
Return on Equity (ROE)		 0.00% 257.04% -39.48% -23.64% -44.51% -29.49% -27.83%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% -374.66% -210.89% -49.37% -32.58% -45.90%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% -20.75% -31.55% -23.96% -26.33%
Return on Assets (ROA)		 0.00% 0.00% 0.00% -20.62% -36.70% -25.72% -24.97%
Return on Common Equity (ROCE)		 0.00% 257.04% -39.48% -23.64% -44.51% -29.49% -27.83%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 257.04% -18.99% -21.15% -52.26% -31.09% -28.30%
Net Operating Profit after Tax (NOPAT)		 -1.33 -16 -31 -43 -82 -44 -40
NOPAT Margin		 0.00% 0.00% 0.00% -3,304.49% -960.56% -442.33% -352.05%
Net Nonoperating Expense Percent (NNEP)		 0.00% -170.53% -11.81% -10.22% -24.91% -19.50% -20.65%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - -20.67%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 215.95% 180.21% 166.55% 194.03%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 2,661.73% 480.93% 245.05% 199.02%
R&D to Revenue		 0.00% 0.00% 0.00% 1,313.04% 309.01% 262.99% 178.87%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 4,604.75% 1,529.56% 610.65% 408.91%
Earnings before Interest and Taxes (EBIT)		 -1.90 -23 -44 -62 -97 -57 -56
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.87 -23 -44 -60 -84 -44 -45
Valuation Ratios		 - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 1.82 2.29 1.76 1.80 2.20
Price to Tangible Book Value (P/TBV)		 0.00 0.00 1.82 5.08 3.24 3.05 3.49
Price to Revenue (P/Rev)		 0.00 0.00 0.00 514.03 44.56 35.43 36.87
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 11.90 3.71 2.36 2.33 2.69
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 397.00 33.47 27.46 32.03
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 172.78 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - -
Debt to Equity		 0.00 -0.02 0.00 0.01 0.04 0.02 0.02
Long-Term Debt to Equity		 0.00 0.00 0.00 0.01 0.02 0.00 0.00
Financial Leverage		 0.00 0.90 -1.00 -0.70 -0.49 -0.42 -0.35
Leverage Ratio		 0.00 -1.35 1.12 1.15 1.21 1.15 1.11
Compound Leverage Factor		 0.00 -1.35 1.11 1.14 1.46 1.24 1.06
Debt to Total Capital		 0.00% -1.62% 0.00% 1.33% 3.45% 1.75% 1.59%
Short-Term Debt to Total Capital		 0.00% -1.62% 0.00% 0.05% 1.89% 1.75% 1.59%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 1.28% 1.55% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 101.62% 100.00% 98.67% 96.56% 98.25% 98.41%
Debt to EBITDA		 0.00 -0.01 0.00 -0.07 -0.09 -0.08 -0.07
Net Debt to EBITDA		 0.00 0.35 0.00 2.54 1.13 1.79 1.22
Long-Term Debt to EBITDA		 0.00 0.00 0.00 -0.06 -0.04 0.00 0.00
Debt to NOPAT		 0.00 -0.01 0.00 -0.09 -0.09 -0.08 -0.08
Net Debt to NOPAT		 0.00 0.50 0.00 3.54 1.15 1.80 1.38
Long-Term Debt to NOPAT		 0.00 0.00 0.00 -0.09 -0.04 0.00 0.00
Altman Z-Score		 0.00 -7.34 46.52 4.68 3.77 6.64 9.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - -
Current Ratio		 0.00 0.48 49.06 1.80 3.29 5.71 5.63
Quick Ratio		 0.00 0.40 47.65 1.70 3.13 5.40 4.26
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.91 -65 -165 -64 -39 -58
Operating Cash Flow to CapEx		 -5,028.77% -4,419.20% -155.05% -164.35% -605.01% -1,355.65% -1,322.66%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.03 0.04 0.05
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 8.46 8.05 6.86
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 11.38
Fixed Asset Turnover		 0.00 0.00 0.00 0.05 0.21 0.23 0.26
Accounts Payable Turnover		 0.00 0.00 0.00 1.58 4.58 4.77 7.94
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 43.15 45.34 53.20
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 32.09
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 231.30 79.73 76.58 45.95
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 -231.30 -36.58 -31.23 39.34
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 0.00 -17 17 140 122 117 134
Invested Capital Turnover		 0.00 0.00 0.00 0.02 0.07 0.08 0.09
Increase / (Decrease) in Invested Capital		 0.00 -17 34 122 -18 -5.01 18
Enterprise Value (EV)		 0.00 157 206 518 287 272 361
Market Capitalization		 165 165 419 670 382 351 416
Book Value per Share		 $0.00 ($0.35) $6.47 $6.34 $4.18 $3.55 $3.27
Tangible Book Value per Share		 $0.00 ($0.35) $6.47 $2.86 $2.28 $2.09 $2.06
Total Capital		 0.00 -8.64 231 296 224 199 192
Total Debt		 0.00 0.14 0.00 3.94 7.73 3.49 3.06
Total Long-Term Debt		 0.00 0.00 0.00 3.80 3.48 0.00 0.00
Net Debt		 0.00 -7.93 -213 -153 -95 -79 -55
Capital Expenditures (CapEx)		 0.07 0.13 14 23 7.17 3.30 2.77
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -19 1.85 -46 -16 -5.83 10
Debt-free Net Working Capital (DFNWC)		 0.00 -10 215 42 62 77 68
Net Working Capital (NWC)		 0.00 -11 215 42 57 73 65
Net Nonoperating Expense (NNE)		 0.58 6.76 13 19 31 17 14
Net Nonoperating Obligations (NNO)		 0.00 -7.93 -213 -153 -95 -79 -55
Total Depreciation and Amortization (D&A)		 0.04 0.05 0.21 2.08 13 13 11
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% -3,562.88% -186.37% -58.84% 89.19%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 3,240.11% 718.55% 773.36% 600.63%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 3,228.99% 669.00% 738.12% 573.50%
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($1.23) ($1.28) ($2.17) ($1.08) ($0.91)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 46.10M 48.22M 52.24M 56.37M 58.67M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($1.23) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 46.10M 51.79M 55.09M 57.78M 58.67M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($1.23) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 35.65M 51.79M 55.09M 57.78M 58.67M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.33 -16 -31 -43 -47 -39 -40
Normalized NOPAT Margin		 0.00% 0.00% 0.00% -3,304.49% -545.38% -389.89% -352.05%
Pre Tax Income Margin		 0.00% 0.00% 0.00% -4,742.79% -1,363.03% -617.01% -477.48%
Debt Service Ratios		 - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Nano-X Imaging

No quarterly metrics and ratios for Nano-X Imaging are available.

Frequently Asked Questions About Nano-X Imaging's Financials

When does Nano-X Imaging's financial year end?

According to the most recent income statement we have on file, Nano-X Imaging's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Nano-X Imaging's net income changed over the last 6 years?

Nano-X Imaging's net income appears to be on an upward trend, with a most recent value of -$53.52 million in 2024, rising from -$1.91 million in 2018. The previous period was -$60.78 million in 2023.

What is Nano-X Imaging's operating income?
Nano-X Imaging's total operating income in 2024 was -$56.75 million, based on the following breakdown:
  • Total Gross Profit: -$10.61 million
  • Total Operating Expenses: $46.14 million
How has Nano-X Imaging revenue changed over the last 6 years?

Over the last 6 years, Nano-X Imaging's total revenue changed from $0.00 in 2018 to $11.28 million in 2024, a change of 1,128,300,000.0%.

How much debt does Nano-X Imaging have?

Nano-X Imaging's total liabilities were at $20.88 million at the end of 2024, a 9.7% decrease from 2023, and a 1.1% increase since 2019.

How much cash does Nano-X Imaging have?

In the past 5 years, Nano-X Imaging's cash and equivalents has ranged from $8.07 million in 2019 to $213.47 million in 2020, and is currently $39.30 million as of their latest financial filing in 2024.

How has Nano-X Imaging's book value per share changed over the last 6 years?

Over the last 6 years, Nano-X Imaging's book value per share changed from 0.00 in 2018 to 3.27 in 2024, a change of 327.3%.


Related Companies

This page (NASDAQ:NNOX) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners
The Last Time This Happened, Americans Lost Billions
Wall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...
Banyan Hill Publishing | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...
Paradigm Press | Sponsored
Gold Alert: The Truth About Fort Knox Is Coming
Owning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...
Golden Portfolio | Sponsored
DOGE officially begins retirement transformation
Elon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...
Altimetry | Sponsored
Do this Before Elon's Reveal on April 23rd
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...
Brownstone Research | Sponsored